Related Experiment Videos
Early changes in fluorine-18-FDG uptake during radiotherapy
H Hautzel1, H W Müller-Gärtner
1Institute for Medicine, Research Center Jülich, Germany.
Summary
External radiotherapy initially increases tumor metabolism, measurable by fluorodeoxyglucose-positron emission tomography (FDG-PET). However, sustained high radiation doses lead to declining metabolic activity, potentially influenced by inflammation.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiotherapy
Background:
- External radiotherapy is a cornerstone in cancer treatment.
- Monitoring tumor response to radiotherapy is crucial for treatment optimization.
- Metabolic changes in tumors during radiation can indicate treatment efficacy and resistance.
Observation:
- This case study quantified metabolic changes in thyroid cancer lymph node metastases during and after external radiotherapy.
- Fluorodeoxyglucose-positron emission tomography (FDG-PET) and antigranulocyte antibody scintigraphy were employed.
- Serial FDG-PET scans assessed glucose metabolism, while scintigraphy evaluated inflammatory response.
Findings:
- FDG-PET revealed an initial increase in tracer uptake in both metastases post-radiotherapy initiation (6 Gy).
- Metabolic activity subsequently declined with increasing radiation dose.
- A superficial metastasis showed persistently high FDG uptake even after 60 Gy, correlating with intense inflammation detected by antigranulocyte scan, unlike a deep metastasis that returned to baseline after 30 Gy.
Implications:
- Irradiation can transiently enhance tumor metabolism, detectable by FDG-PET.
- Sustained high radiation doses correlate with decreasing metabolic activity.
- Inflammatory reactions in tumors may contribute to observed glucose uptake, potentially affecting FDG-PET interpretation during radiotherapy.